Advancing The Profession of Pharmacy

[Podcast] Interview with Genomics, Inc Founder Bob Ragot

by | Sep 29, 2016 | MTM Entrepreneurship

This episode Bob and I talked about one of the most exciting new opportunities in pharmacist led clinical services: pharmacogenomic testing.

Pharmacogenomics is a dynamic industry that pharmacists are well-positioned to inherit.

Some key takeaways from our discussion:

  • Why PGx has failed in the community pharmacy and in acute care settings¬†in the past
  • Moving away from the traditional third party billing model
  • How developing genetic tests will become the model for comprehensive Pharmacogenetic detection and informed treatment
  • How limiting scope of testing alleviates prescriber hesitation due to liability issues
  • How can pharmacists act as the gatekeepers for the patient’s comprehensive report
  • Using pre-emptive genotyping to reduce trial and error prescribing
  • How PGx testing allows Pharmacogenetic and the therapeutic considerations that can improve treatment outcomes and quality of life
  • Enhancing the safety and effectiveness of anticoagulation drugs

About the Author

Blair Thielemier, PharmD, is an MTM consultant pharmacist specializing in pharmacy billing models. She consults on and produces e-learning programs for state and national organizations, pharmacy wholesalers, payers, technology start-ups. She has books and online courses available for individuals looking to leverage their pharmacy knowledge into monetized clinical programs at PharmapreneurAcademy.com. She speaks internationally about trends in leveraging pharmacists to improve value-based care.

 

Let Us Help You Become
THE Pharmacist To Call

Join today!

 

Consulting Pharmacists Education Archive